ACR 2020 Debate: JAK Inhibitors vs Biologics After Methotrexate Failure in RA
Experts at the ACR Convergence conference discussed the use of Janus kinase inhibitors before/after biologics following methotrexate treatment failure in RA.
Experts at the ACR Convergence conference discussed the use of Janus kinase inhibitors before/after biologics following methotrexate treatment failure in RA.
Researchers evaluated the safety and efficacy of belimumab plus standard therapy in patients with active lupus nephritis.
Researchers evaluated the safety and efficacy of tofacitinib for the treatment of patients with ankylosing spondylitis.
Study authors identified cross-cutting disease factors affecting the mental health of youth with rheumatologic disease.
Study authors conducted a systematic review to assess the use of cannabis and its impact on pain in patients with rheumatic diseases.
Researchers compared the beneficial effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on gout risk in patients with type 2 diabetes.
The long-term safety and efficacy of tocilizumab in patients with systemic sclerosis were assessed in an open-label study.
Burden and progression of coronary atherosclerosis was found to be worsened in non-obese patients with rheumatoid arthritis and low vs high LDL levels.
Study authors evaluated the effect of complement C5a receptor inhibitor avacopan on renal function in ANCA-associated vasculitis.
During the COVID-19 pandemic, healthcare teams have realized the potential of telemedicine in pediatric rheumatology practices.